Founded as a spin-out company in 2019, the technology was originally developed by the Defence Science and Technology Laboratory (DSTL), designed to identify and predict those who are at particular risk of developing sepsis, using a set of biomarkers. Presymptom’s technology has the potential to be directly relevant for Covid-19 patients, which will provide vital and life-saving information. The scientists involved in the development of the technology were awarded the The Sun’s 2018 “Millie” Innovation Award.
© Ploughshare Innovations Ltd 2025. Registered in England and Wales No. 04401901